MONEY TALKS

GT (UK) - - COMMUNITY - MIKE FREER, TORY MP FOR FINCHLEY AND GOLDERS GREEN, AND CHAIR OF THE ALL-PARTY PAR­LIA­MEN­TARY GROUP ON HIV/AIDS, @MIKEFREERMP

I’ve long ar­gued for PrEP be­ing made avail­able on the NHS, but I do un­der­stand that the de­ci­sion has to be based not just on clin­i­cal grounds, but that it also has to meet the NHS ap­plies to all new treat­ments.

It sounds harsh to look at new treat­ment, but the NHS is al­ways un­der pres­sure – de­spite ever in­creas­ing treat­ments. I’ve just se­cured vac­ci­na­tion pro­gramme to MSM, I’m cam­paign­ing to ex­tend this to all boys, oth­ers are cam­paign­ing on mak­ing new breast can­cer drugs avail­able, and menin­gi­tis vac­ci­na­tion to be given to all ba­bies. Hence ap­proval takes time.

It’s also worth re­mem­ber­ing that the UK con­tin­ues to pre­ven­tion and treat­ment; and we are world lead­ers in in the de­vel­op­ing world. So is not a cure and it is not a vac­cine, but it is and can be a would still have to re­it­er­ate the mes­sage about us­ing aren’t the only ones on the drug-re­sis­tant gon­or­rhoea, we can’t al­low our­selves to

The is­sue is also com­pli­cated by the li­cens­ing At the mo­ment, it is li­censed as a treat­ment. It is not a pre­ven­tive mea­sure. That has to be re­solved. This is patent is­sue. Tru­vada comes would bring down the an­nual the NHS could have more avail­able, or sim­ply al­low the other ar­eas. There is a risk that by mak­ing Tru­vada a pre­ven­ta­tive and treat­ment drug, Gilead could seek an keep­ing the drug at the an­num, rather than see­ing it drop. The NHS pro­cure­ment team has to re­solve this.

Is the UK out on a limb when the health ser­vice is mainly pri­vate or in­sur­ance based, sys­tem are wrestling with the same is­sues as our NHS.

rapid ev­i­dence re­view that will look at the re­source as well as all the clin­i­cal world. It will re­port by This is along­side the trial, which will be larger than avail­able to those most at risk, when a clin­i­cian rec­om­mends it.

The NHS can be slow but we have to make sure the cor­rect ap­proval pro­cesses op­por­tu­nity to be missed.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.